41
Mitsubishi Tanabe
4188.T·TSEOsaka JPFounded 16788,000 employees
Mid CappharmaPublicNeurologyCNS
Platform: Radicava ALS
Market Cap
$5B
All Drugs
3
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (4188.T)
Loading 4188.T stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 418-6056 | 418-6056 | Phase 1/2 | 2 | BCL-2 | NBADPKD | ||
| 418-9392 | 418-9392 | NDA/BLA | 2 | MALT1 | Hemophilia AOvarian Ca | ||
| 418-7316 | 418-7316 | Phase 2/3 | 2 | KRASG12C | RAMDD |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
Mitsubishi Tanabe trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)